Clinical Trial Results:
Avastin / Irinotecan in patients with recurrent or progressive malignant glioma
An academic prospective single-arm phase II clinical trial for evaluation of advanced functional neuroimaging techniques and molecular markers in the course of anti-angiogenic therapies in malignant gliomas
Summary
|
|
EudraCT number |
2009-015036-15 |
Trial protocol |
AT |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
27 Jan 2017
|
First version publication date |
27 Jan 2017
|
Other versions |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.